Loading...
Chemical structure of DCC-3014

GC39623

DCC-3014

Also known as 3-methyl-5-[6-methyl-5-[[2-(1-methylpyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-(propan-2-ylamino)pyrimidin-4-one

DCC-3014 (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of ＜0·01 μM and 0·1-1 μM, respectively

ChemicalCAS1628606-05-2MW431.49FormulaC23H25N7O2
CAS number
1628606-05-2
Molecular weight
431.49
Formula
C23H25N7O2
Solubility
Soluble in DMSO
InChIKey
TVGAHWWPABTBCX-UHFFFAOYSA-N
Catalogue number
GC39623
Brand
GLPBIO
Computed properties PubChem CID 86267612 · XLogP 1.5 · TPSA 97.5 Ų · H-bond donors 1
XLogP
1.5
TPSA
97.5 Ų
H-bond donors
1
H-bond acceptors
6
Rotatable bonds
6
Heavy atoms
32

SMILES CC1=C(C=CC(=N1)C2=CN=C(N(C2=O)C)NC(C)C)OC3=CC(=NC=C3)C4=CN(N=C4)C

Computed descriptors from PubChem (CID 86267612), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.